131 related articles for article (PubMed ID: 8284135)
1. Chemoprophylaxis in asplenic adolescents and young adults.
Buchanan GR
Pediatr Infect Dis J; 1993 Oct; 12(10):892-3. PubMed ID: 8284135
[No Abstract] [Full Text] [Related]
2. [New vaccines].
Ozişik A; Ustaçelebi S
Mikrobiyol Bul; 1992 Jan; 26(1):82-9. PubMed ID: 1574025
[TBL] [Abstract][Full Text] [Related]
3. Salvage splenic function after traumatic injury.
Sing RF; Phillips GR; Kauder DR; Schwab CW
J Trauma; 1993 Jun; 34(6):916. PubMed ID: 8315693
[No Abstract] [Full Text] [Related]
4. Vaccination considerations in the asplenic patient.
Shatz DV
Expert Rev Vaccines; 2005 Feb; 4(1):27-34. PubMed ID: 15757471
[TBL] [Abstract][Full Text] [Related]
5. Current immunization practices. 2. Hemophilus influenzae, pneumococcal, and meningococcal infections, rabies, and hepatitis.
Gillum JE; Garrison MW; Crossley KB; Rotschafer JC
Postgrad Med; 1989 Feb; 85(2):199-202, 207-10. PubMed ID: 2783778
[No Abstract] [Full Text] [Related]
6. [Bacterial polysaccharide vaccines: Meningococcus, Pneumococcus, Haemophilus influenzae].
Triau R
Rev Prat; 1984 Jun; 34(31):1683-90. PubMed ID: 6429835
[No Abstract] [Full Text] [Related]
7. Haemophilus influenzae type b vaccine.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1988 Jan; 36(50-51):832. PubMed ID: 3121998
[No Abstract] [Full Text] [Related]
8. Immune responses to polysaccharides: lessons from humans and mice.
González-Fernández A; Faro J; Fernández C
Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
[TBL] [Abstract][Full Text] [Related]
9. Normal IgG and impaired IgM responses to polysaccharide vaccines in asplenic patients.
Molrine DC; Siber GR; Samra Y; Shevy DS; MacDonald K; Cieri R; Ambrosino DM
J Infect Dis; 1999 Feb; 179(2):513-7. PubMed ID: 9878041
[TBL] [Abstract][Full Text] [Related]
10. Response of transplant patient to pneumococcal vaccine.
Arnold WC; Steele RW; Rastogi SP; Flanigan WJ
Proc Clin Dial Transplant Forum; 1980; 10():57-61. PubMed ID: 7050994
[No Abstract] [Full Text] [Related]
11. Study of the chronic toxicity of D 53 by aerosol. One-year observation.
Fontanges R; Robert D; Isoard P
Arzneimittelforschung; 1980; 30(1a):187-96. PubMed ID: 6989375
[No Abstract] [Full Text] [Related]
12. Use of new bacterial vaccines in children.
Klein JO
Isr J Med Sci; 1983 Nov; 19(11):1026-9. PubMed ID: 6420367
[No Abstract] [Full Text] [Related]
13. [Susceptibility to infection after splenectomy for hematologic disease. Is antipneumococcal vaccination and antibiotic prophylaxis needed?].
Gulías Piñeiro A; Fraguela Mariña J; Fernández Balnco C; Gómez Freijoso C
Sangre (Barc); 1997 Jun; 42(3):259-60. PubMed ID: 9381281
[No Abstract] [Full Text] [Related]
14. Pneumococcal vaccines.
Lancet; 1978 Jan; 1(8056):131-2. PubMed ID: 87558
[No Abstract] [Full Text] [Related]
15. Protection from postsplenectomy sepsis: Effect of prophylactic penicillin and pneumococcal vaccine on clearance of type 3 Pneumococcus.
Scher KS; Wroczynski AF; Jones CW
Surgery; 1983 Jun; 93(6):792-7. PubMed ID: 6407133
[TBL] [Abstract][Full Text] [Related]
16. Postsplenectomy immunologic impairment.
Seybold HM; Warren MM
Tex Med; 1981 Jun; 77(6):60-2. PubMed ID: 7245099
[No Abstract] [Full Text] [Related]
17. [Difficult pneumococcal infections in adults after splenectomy].
Nuutila P; Kotilainen P; Nikoskelainen J
Duodecim; 1990; 106(5):422-6. PubMed ID: 1670110
[No Abstract] [Full Text] [Related]
18. Otitis media: prospects for prevention.
Haggard M
Vaccine; 2008 Dec; 26 Suppl 7():G20-4. PubMed ID: 19094934
[TBL] [Abstract][Full Text] [Related]
19. Postsplenectomy sepsis in an adult following antipneumococcal immunization.
Trooskin SZ; Greco RS
J Med Soc N J; 1982 Mar; 79(3):221-3. PubMed ID: 6979631
[No Abstract] [Full Text] [Related]
20. The efficacy and immunogenicity of Pneumo-23 and ACT-HIB in patients undergoing splenectomy.
Uslu A; Yetiş H; Aykas A; Karagöz A; Doğan M; Simşek C; Nart A; Yüzbaşioğlu MF
Ulus Travma Acil Cerrahi Derg; 2006 Oct; 12(4):277-81. PubMed ID: 17029117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
